Gainers on news: Anthera Pharmaceuticals (ANTH +12.22%) Confirmed Phase 2b PEARL-SC data has been accepted as a late breaking poster presentation at the ACR/ARHP 2012 Annual Scientific Meeting Vertex Pharmaceuticals (VRTX +6.40%) Announced collaborations for Hepatitis C studies with Janssen Pharmaceuticals and GlaxoSmithKline
Decliners on news: Abiomed (ABMD -29.06%) Announced investigation focused on Impella 2.5 regarding marketing and labeling issues Catalyst Pharmaceutical Partners (CPRX -5.73%) Announced strategic collaboration with BioMarin Pharmaceuticals (BMRN) for the rights to Firdapse in North America.






